The saga for Paramount Global (PARA) seems to be nearing an end. Edgar Bronfman Jr. has abandoned his bid for the media giant, clearing the path for Skydance Media's proposed merger. Meanwhile, Eli Lilly (LLY) has significantly dropped the price of its GLP-1 weight-loss drug, Zepbound. The company will sell its lowest dose for $399, and its 5mg dose at $549 for a one-month supply. That's a massive decrease from the current $1,059 price tag.

Yahoo Finance trending tickers include PDD Holdings (PDD), the Coca-Cola Company (KO), and the Cava Group (CAVA).

Key guests include:
9:10 a.m. ET - Ryan Wang, HSBC Chief US Economist
9:30 a.m. ET - Seema Shah, Principal Asset Management Chief Global Strategist
10:05 a.m. ET - Troy Gayeski, FS Investments Chief Market Strategist
10:30 a.m. ET - Rishi Jaluria, Managing Director, Software Equity Research at RBC Capital
11:30 a.m. ET - Ankur Jain, Bilt Rewards Founder & CEO